Skip to content
WELCOME10 — 10% OFF YOUR FIRST ORDER  ·  FREE SHIPPING OVER $300 CAD  ·  COA ON EVERY ORDER

IGF-1 LR3 FAQ: Your Questions Answered

The questions below are the ones that come up specifically about IGF-1 LR3, rather than general peptide questions that apply to everything.

Recombinant 83-residue protein analogue of IGF-1Hormonal & EndocrineMetabolic

In plain English

Most asked: why it needs acid, what "LR3" means, why carrier protein is added, why freeze-thaw is so much worse for this than for peptides, and why a functional test appears on the report.

What IGF-1 LR3 actually is

IGF-1 LR3 is a modified version of insulin-like growth factor 1, a natural growth signal. Two changes were made so that carrier proteins cannot grab and hold it. Crucially, it is a genuine folded protein rather than a simple chain — and that changes every handling rule.

Supplied for laboratory research use only — not for human or animal use.

Research-grade IGF-1 LR3

Third-party tested by HPLC and LC-MS, ≥99% purity, with a Certificate of Analysis on every order. Ships across Canada.

Technical detail below

IGF-1 LR3 — common questions

Why does IGF-1 LR3 need acidic solvent when other compounds do not?

Because it is a folded 83-residue protein rather than a short unstructured peptide. Its solubility is poor near neutral pH; acidifying keeps it protonated and in solution. Dissolving in dilute acetic acid or dilute HCl and then diluting into working buffer is the conventional and correct approach — plain water will often leave visible undissolved material.

What does the "LR3" designation mean?

Long R3: the "Long" refers to a 13-amino-acid N-terminal extension, and "R3" to the arginine substitution at position 3. The arginine change is the functionally important one, reducing affinity for IGF binding proteins so that more of the molecule remains free rather than sequestered.

Why add BSA to IGF-1 LR3 solutions?

Dilute protein solutions lose material to container walls through adsorption, and at the concentrations used in cell work that loss can be a large fraction of the total. Carrier protein such as 0.1% BSA occupies those binding sites so the protein of interest stays in solution. It is routine practice for growth factors and unnecessary for short peptides.

Why is freeze–thaw worse for IGF-1 LR3 than for short peptides?

Because it has a three-dimensional fold, stabilised by three disulfide bonds, that can be lost. Short peptides such as Semax or Epitalon have no tertiary structure to disrupt, so freezing them is comparatively benign. A denatured protein cannot refold on its own, which is why single-use aliquots are standard here.

Why does a bioactivity assay appear on an IGF-1 LR3 COA?

Because chemical purity does not establish correct folding. A misfolded or disulfide-scrambled protein has exactly the same mass and can look clean by HPLC while being functionally inert. Only a functional assay distinguishes them — which is why protein COAs carry checks that peptide COAs do not need.

What IGF-1 LR3 is studied for

IGFBP evasion

The Arg3 substitution reduces binding-protein affinity, which is the entire design rationale.

Cell proliferation

Widely used in cell-culture research as a growth-factor supplement.

Satellite cell activation

Studied in muscle-biology research models.

PI3K/Akt signalling

The canonical downstream pathway examined in IGF-1 receptor research.

Summarizes published preclinical literature. Provided for research reference only; not a claim of efficacy or a description of human use.

More IGF-1 LR3 reference

FAQ reference for other compounds

IGF-1 LR3 overview IGF-1 LR3 calculatorIGF-1 LR3 product details

IGF-1 LR3 is supplied strictly as a research chemical for in-vitro laboratory and research use only. It is not intended for human or animal consumption, diagnostic, or therapeutic use. This page is educational laboratory-handling reference information — not medical advice, not usage guidance, and not a protocol.